Posted inBusiness Novartis Heart Disease Drug Fails Critical Clinical Trial Novartis faces a setback as its experimental heart disease medication fails a crucial clinical trial evaluating a novel therapeutic approach. Posted by srkanalytics.srk@gmail.com October 1, 2026